National Asset Reconstruction Company Limited (NARCL), has offered to acquire around INR 11,000 million in loans of Parenteral Drugs (India) from the State Bank of India (NSEI:SBIN) and Punjab National Bank (NSEI:PNB). The offer has triggered a Swiss challenge auction, said two people aware of the development.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.39 INR | +4.63% | -.--% | -.--% |
2023 | PSBs Reportedly Shelve Deal to Sell Drug Company Loans to NARCL | CI |
2023 | NARCL Reportedly Offers to Buy INR 11,000 million Loans of Parenteral Drugs | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
873.7 INR | +5.22% | +4.71% | 88.79B | ||
133.7 INR | +3.28% | +3.36% | 17.08B | ||
3.39 INR | +4.63% | -.--% | 1.21M | ||
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.21M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- PDPL Stock
- News Parenteral Drugs (India) Limited
- NARCL Reportedly Offers to Buy INR 11,000 million Loans of Parenteral Drugs